In an adult without contraindications, will Celexa (citalopram) be effective for treating skin‑picking (excoriation) disorder?

Celexa (Citalopram) for Skin-Picking Disorder

Celexa (citalopram) and other SSRIs show the most promising pharmacologic results for skin-picking disorder, but cognitive-behavioral therapy with habit reversal training should be attempted first, with SSRIs reserved as second-line treatment for moderate to severe cases that haven't responded to behavioral interventions. 1, 2

Treatment Algorithm

First-Line: Behavioral Interventions

• Start with cognitive-behavioral therapy (CBT) incorporating habit reversal training, which includes awareness training, development of competing responses, and self-monitoring tools 1
• Exposure with response prevention (ERP) techniques should be integrated to reduce avoidance behaviors 1
• Both individual and group CBT formats are equally effective, allowing flexibility based on patient preference and resource availability 1

Second-Line: Pharmacologic Treatment

When to initiate SSRIs:

• Inadequate response to CBT after appropriate trial 1
• Moderate to severe functional impairment present 1
• Comorbid anxiety or depression exists 1
• CBT is unavailable or not tolerated 1

SSRI Evidence:

• SSRIs (including citalopram) demonstrate the most promising results in mitigating severity and frequency of skin-picking symptoms 2
• Fluoxetine and escitalopram specifically have documented improvement in skin picking 2, 3
• SSRIs are increasingly used in combination with psychotherapy when patients present with skin-picking disorder 2

Alternative Pharmacologic Options

N-Acetylcysteine (NAC):

• Well-established glutamatergic agent with minimal side effects 1
• Dosed at 1200-2400 mg/day in divided doses 1
• Has robust evidence as an alternative to SSRIs 2, 4

Other agents with limited evidence:

• Olanzapine (antipsychotic augmentation) 2, 4
• Naltrexone (opioid antagonist) 2
• Lamotrigine (lacks robust evidence) 1, 2

Critical Monitoring Requirements

Assessment timeline:

• Evaluate treatment response at 4 weeks and 8 weeks using standardized measures 1
• Adjust regimen if symptoms are stable or worsening despite good adherence 1

Risk assessment at every visit:

• Screen for self-harm and suicidal ideation, as skin-picking disorder carries elevated psychiatric risk 1
• Assess functional impairment in self-care, usual activities, and social functioning to guide treatment intensity 1
• Monitor for infection, scarring, and tissue damage from picking 1

Important Caveats

Paradoxical effects:

• SSRIs can rarely cause or worsen skin picking and compulsive behaviors in some patients, particularly in children 5
• If skin picking emerges or worsens after SSRI initiation, consider dose reduction or medication change 5

Stimulant consideration:

• If patient is on stimulant medication, assess whether it is contributing to or exacerbating skin picking 1
• Dose reduction or medication holiday may be warranted if stimulants are implicated 1

Avoid long-term sedating antihistamines:

• These may predispose to dementia and should not be used as chronic treatment 1

Adjunctive Strategies

• Online self-help programs with educational materials and CBT-based exercises show moderate effect sizes 1
• Regular stress management techniques and relaxation training can reduce picking triggers 1
• Family involvement is crucial, especially for younger patients, to support and reinforce behavioral strategies 1